Foundation Medicine Inc (FMI) financial statements (2020 and earlier)

Company profile

Business Address 150 SECOND STREET
CAMBRIDGE, MA 02141
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7114320772124
Cash and cash equivalents716411872124
Short-term investments 7990  
Receivables30108106
Inventory, net of allowances, customer advances and progress billings1310852
Inventory1310852
Other undisclosed current assets95731
Total current assets:12416923090133
Noncurrent Assets
Property, plant and equipment4141412122
Long-term investments and receivables  25  
Long-term investments  25  
Restricted cash and investments21112
Other noncurrent assets22100
Total noncurrent assets:4545682224
TOTAL ASSETS:169214298112157
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5932232015
Accounts payable22121077
Accrued liabilities37211375
Employee-related liabilities   53
Debt    1
Deferred revenue and credits44322
Other undisclosed current liabilities444(5)(3)
Total current liabilities:6641301616
Noncurrent Liabilities
Liabilities, other than long-term debt60  910
Deferred revenue and credits   910
Due to related parties60    
Total noncurrent liabilities:60  910
Total liabilities:12641302625
Stockholders' equity
Stockholders' equity attributable to parent3216525886132
Common stock00000
Additional paid in capital538510489228221
Accumulated other comprehensive income (loss)0(0)(0)  
Accumulated deficit(506)(345)(232)(142)(90)
Total stockholders' equity:3216525886132
Other undisclosed liabilities and equity1191000
TOTAL LIABILITIES AND EQUITY:169214298112157

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues153117936129
Revenue, net 1179311
Cost of revenue(67)(53)(37)(27)(12)
Gross profit:8664573417
Operating expenses(247)(174)(144)(95)(65)
Other undisclosed operating income (loss) (4)(3)85
Operating loss:(161)(114)(90)(53)(42)
Nonoperating income (expense)0101(1)
Other nonoperating income (expense)0  1(1)
Interest and debt expense(0)    
Net loss:(161)(113)(90)(52)(43)
Other undisclosed net loss attributable to parent(0)    
Net loss attributable to parent:(161)(113)(90)(52)(43)
Preferred stock dividends and other adjustments    (0)
Net loss available to common stockholders, diluted:(161)(113)(90)(52)(43)

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(161)(113)(90)(52)(43)
Other comprehensive income (loss)00(0)  
Comprehensive loss:(161)(113)(90)(52)(43)
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)    
Comprehensive loss, net of tax, attributable to parent:(161)(113)(90)(52)(43)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: